MetaCap

Shuttle Pharmaceuticals (SHPH) vs TherapeuticsMD (TXMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

TherapeuticsMD (TXMD) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, gaining 89.6% versus a loss of 87.4%. Shuttle Pharmaceuticals is the larger company by market cap ($26.4 million vs $23.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SHPH-87.36%TXMD+89.62%
+174%+34%-106%
Oct 8, 20251 yearOct 8, 2026
SHPH-99.98%TXMD-80.26%
+173%+30%-113%
Aug 29, 20225 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SHPH versus TXMD key metrics
MetricSHPHTXMD
Share price$5.55$2.01
Market cap$26.44M$23.26M
1-day change+17.83%+0.50%
YTD return-69.17%+23.31%
1-year return-87.36%+89.62%
5-year return—-94.42%
Forward P/E—5.74
EPS (TTM)$-16.87$-0.04
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$55.90$2.95
52-week low$2.58$1.03
Distance from 52-week high-90.07%-31.86%
Average volume1.36M23.94K
Shares outstanding4.76M11.57M
Employees21
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TXMD has outperformed SHPH by 177.0 percentage points over the past year.

About Shuttle Pharmaceuticals

SHPH stock →

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.

Healthcare · Drug Manufacturers - Specialty & Generic · 2 employees

About TherapeuticsMD

TXMD stock →

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.

Healthcare · Drug Manufacturers - Specialty & Generic · 1 employees

SHPH vs TXMD FAQ

Which is bigger, Shuttle Pharmaceuticals or TherapeuticsMD?

Shuttle Pharmaceuticals (SHPH) is larger, with a market capitalization of $26.44M compared with $23.26M for TherapeuticsMD (TXMD).

Which stock has performed better over the past year, SHPH or TXMD?

TXMD returned +89.62% over the past 12 months, compared with -87.36% for SHPH (price return, excluding dividends). Past performance does not predict future results.

Are Shuttle Pharmaceuticals and TherapeuticsMD in the same industry?

Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

More comparisons